Phlebologie 2014; 43(02): 84-88
DOI: 10.12687/phleb2182-2-2014
Original article
Schattauer GmbH

Foot sling for the treatment of diurnal leg oedema: effect due to foot muscle pump stimulation?

Case series Article in several languages: English | deutsch
M. Doerler
1   Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum, Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum
,
S. Reich-Schupke
2   Kompetenzzentrum für Phlebologie und Dermatologie, Artemed Fachklinik, Bad Oeynhausen
,
P. Selanski-Porto
1   Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum, Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum
,
P. Altmeyer
1   Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum, Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum
,
M. Stücker
1   Klinik für Dermatologie, Venerologie und Allergologie der Ruhr-Universität Bochum, Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Ruhr-Universität Bochum
› Author Affiliations
Further Information

Publication History

Received: 04 December 2013

Accepted: 03 February 2014

Publication Date:
04 January 2018 (online)

Summary

Background and objectives: Prospective pilot case series to evaluate the efficacy, tolerability and ease of use of a novel foot sling (Stimfeet) for the treatment of diurnal leg oedema.

Patients and methods: We included 8 female patients with detectable pretibial pitting due to diurnal leg oedema. Hemodynamically relevant reflux or obstruction of the leg veins was ruled out by duplex ultrasonography. The patients wore knee-length medical compression stockings (MCS, 18–23 mmHg) all day for one week and, after a two-day break, used Stimfeet devices (maximum of four hours uninterrupted use) for one week, or vice versa. Before and after each treatment week, two water plethysmographic volume measurements were performed on each leg. Efficacy, tolerability and the ease of use were evaluated by means of a standardised questionnaire. Side effects were documented in a patient diary.

Results: Volume reduction was greater with MCS therapy (mean Δ right leg: 39.00 g, left leg: 24.44 g) than with Stimfeet (mean Δ right leg: 5.06 g, left leg: 2.81 g). However, the difference was not significant (t-test: right leg, p=0.55; left leg, p=0.63). More patients preferred the MCS with respect to reduction of impairment (n=5), comfort (n=6), symptom reduction (n=5), improvement in quality of life (n=5), improvement of working conditions (n=5), and meeting expectations (n=5). The ease of use was rated equally. The most commonly reported side effects of Stimfeet were pressure and chafing marks (n=6), and slip-ping/need for fixation of the device (n=5).

Conclusions: MCS therapy was superior to the novel foot sling for the treatment of diurnal leg oedema. However, the Stimfeet device did lead to an improvement of symptoms and reduced oedema in a few of the patients. Its efficacy possibly depends on the stimulation of the foot muscle pump. Methods of activating the foot muscle pump represent a novel therapeutic option for the treatment of diurnal leg oedema.

 
  • References

  • 1 Blaettler W, Kreis N, Lun B, Winiger J, Amsler F. Leg symptoms of healthy people and their treatment with compression hosiery. Phlebology 2008; 23 (05) 214-221.
  • 2 Blaettler W, Amsler F, Mendoza E. The relative impact on leg symptoms of fears of getting varicose veins and of great saphenous vein reflux. Phlebology 2013; 28 (07) 347-352.
  • 3 Amsler F, Blaettler W. Compression therapy for occupational leg symptoms and chronic venous disorders – a meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg 2008; 35 (03) 366-372.
  • 4 Mudge E, Holloway S, Simmonds W, Price P. Living with venous leg ulceration: issues concerning adherence. Br J Nurs 2006; 15 (21) 1166-1171.
  • 5 Blazek C, Amsler F, Blaettler W, Keo HH, Baumgartner I, Willenberg T. Compression hosiery for occupational leg symptoms and leg volume: a randomized crossover trial in a cohort of hairdressers. Phlebology 2013; 28 (05) 239-247.
  • 6 Partsch H, Flour M, Smith PC. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Under the auspices of the IUP. Int Angiol 2008; 27 (03) 193-219.
  • 7 Rabe E, Hertel S, Bock E, Hoffmann B, Jockel KH, Pannier F. Therapy with compression stockings in Germany – results from the Bonn Vein Studies. J Dtsch Dermatol Ges 2013; 11 (03) 257-261.
  • 8 Uhl JF, Gillot C. Anatomy of the foot venous pump: physiology and influence on chronic venous disease. Phlebology 2012; 27 (05) 219-30.
  • 9 White JV, Katz ML, Cisek P, Kreithen J. Venous outflow of the leg: anatomy and physiologic mechanism of the plantar venous plexus. J Vasc Surg 1996; 24 (05) 819-824.
  • 10 Broderick BJ, Corley GJ, Quondamatteo F, Grace PA, Breen PP, Olaighin G. A haemodynamic study of the physiological mechanisms of the venous pump in the healthy human foot. Conf Proc IEEE Eng Med Biol Soc 2008; 1411-1414.
  • 11 Tedeschi Filho W, Dezzotti NR, Joviliano EE, Moriya T, Piccinato CE. Influence of high-heeled shoes on venous function in young women. J Vasc Surg 2012; 56 (04) 1039-1044.
  • 12 Bergqvist D. Antiswelling effect of StepIt--an active foot pump system. J Am Podiatr Med Assoc 2009; 99 (01) 20-22.
  • 13 Belczak CE, de Godoy JM, Ramos RN, de Oliveira MA, Belczak SQ, Caffaro RA. Is the wearing of elastic stockings for half a day as effective as wearing them for the entire day?. Br J Dermatol 2010; 162 (01) 42-45.
  • 14 Stewart JM, Karman C, Montgomery LD, McLeod KJ. Plantar vibration improves leg fluid flow in perimenopausal women. Am J Physiol Regul Integr Comp Physiol 2005; 288 (03) R623-629.
  • 15 IO WM, Lepar GS, Morrissey MC, Cywinski JK. Effect of neuromuscular electrical stimulation on foot/ankle volume during standing. Med Sci Sports Exerc 2003; 35 (04) 630-634.